3-Bromo-7-nitroindazole

Pricing Availability Delivery Time Qty
Cat.No. 0735 - 3-Bromo-7-nitroindazole | C7H4BrN3O2 | CAS No. 74209-34-0
Description: Selective nNOS inhibitor
Purity: ≥98% (HPLC)
Datasheet
Citations (1)
Literature

Biological Activity

Potent inhibitor of rat cerebellar nitric oxide synthase; more potent than 7-nitroindazole (Cat. No. 0602).

Compound Libraries

3-Bromo-7-nitroindazole is also offered as part of the Tocriscreen Plus. Find out more about compound libraries available from Tocris.

Technical Data

M. Wt 242.03
Formula C7H4BrN3O2
Storage Desiccate at +4°C
Purity ≥98% (HPLC)
CAS Number 74209-34-0
PubChem ID 1649
InChI Key NFSTZPMYAZRZPC-UHFFFAOYSA-N
Smiles [O-][N+](=O)C1=C2NN=C(Br)C2=CC=C1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

All Tocris products are intended for laboratory research use only.

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 24.2 100
ethanol 12.1 50

Preparing Stock Solutions

The following data is based on the product molecular weight 242.03. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 4.13 mL 20.66 mL 41.32 mL
5 mM 0.83 mL 4.13 mL 8.26 mL
10 mM 0.41 mL 2.07 mL 4.13 mL
50 mM 0.08 mL 0.41 mL 0.83 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

Product Datasheets

Safety Datasheet

References

References are publications that support the products' biological activity.

Bland-Ward and Moore (1995) 7-Nitroindazole derivatives are potent inhibitors of brain, endothelium and inducible isoforms of nitric oxide synthase. Life Sci. 57 PL131 PMID: 7544863

Bland-Ward et al (1994) Isoform selectivity of indazole-based nitric oxide synthase inhibitors. Br.J.Pharmacol. 112 351P PMID:


If you know of a relevant reference for 3-Bromo-7-nitroindazole, please let us know.

View Related Products by Target

View Related Products by Product Action

View all nNOS Inhibitors

Keywords: Selective nNOS inhibitors inhibits Nitric Oxide Signaling Signalling Neuronal NO Synthases nNOS

1 Citation for 3-Bromo-7-nitroindazole

Citations are publications that use Tocris products. Selected citations for 3-Bromo-7-nitroindazole include:

Dai et al (2011) Lactate dilates cochlear capillaries via type V fibrocyte-vessel coupling signaled by nNOS. Am J Physiol Heart Circ Physiol 301 H1248 PMID: 21856924


Do you know of a great paper that uses 3-Bromo-7-nitroindazole from Tocris? If so please let us know.

Commented out for usability testing

Reviews

TODO: Add Reviews

Literature in this Area

Cancer

Cancer Research Product Guide

A collection of over 750 products for cancer research, the guide includes research tools for the study of:

  • Cancer Metabolism
  • Epigenetics in Cancer
  • Receptor Signaling
  • Cell Cycle and DNA Damage Repair
  • Angiogenesis
  • Invasion and Metastasis
Neurodegeneration

Neurodegeneration Product Guide

A collection of over 275 products for neurodegeneration research, the guide includes research tools for the study of:

  • Alzheimer's disease
  • Parkinson's disease
  • Huntington's disease
Schizophrenia

Schizophrenia Poster

Schizophrenia is a debilitating psychiatric disorder that affects 1% of the worldwide population. This poster describes the neurobiology of Schizophrenia, as well as highlighting the genetic and environmental factors that play a fundamental role in the etiology of the disease. The current and emerging drug targets are also discussed.

Pathways for 3-Bromo-7-nitroindazole

Protocols

TODO: Add Protocols